Heterogeneity in treatment response in patients with HER2 positive breast cancer

10.1016/s0960-9776(19)30068-2 ◽

2019 ◽

Vol 44 ◽

pp. S3-S4

Author(s):

A. Prat

Keyword(s):

Breast Cancer ◽

Treatment Response ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

Heterogeneity in treatment response in patients with HER2 positive breast cancer

10.1016/s0960-9776(19)30071-2 ◽

2019 ◽

Vol 44 ◽

pp. S5

Author(s):

L.A. Carey

Keyword(s):

Breast Cancer ◽

Treatment Response ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

Impact of HER2 heterogeneity on treatment response of early-stage HER2-positive breast cancer: phase II neoadjuvant clinical trial of T-DM1 combined with pertuzumab

Cancer Discovery ◽

10.1158/2159-8290.cd-20-1557 ◽

2021 ◽

pp. candisc.1557.2020

Author(s):

Otto Metzger Filho ◽

Giuseppe Viale ◽

Shayna Stein ◽

Lorenzo Trippa ◽

Denise A Yardley ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Treatment Response ◽

Phase Ii ◽

Early Stage ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Her2 Heterogeneity ◽

Positive Breast Cancer

Download Full-text

Abstract P5-10-09: Prediction of Trastuzumab treatment response for HER2-positive breast cancer by microRNA profiling

10.1158/0008-5472.sabcs12-p5-10-09 ◽

2012 ◽

Author(s):

F Sato ◽

Z Wang ◽

T Ueno ◽

A Myomoto ◽

S Takizawa ◽

...

Keyword(s):

Breast Cancer ◽

Treatment Response ◽

Her2 Positive ◽

Trastuzumab Treatment ◽

Her2 Positive Breast Cancer ◽

Microrna Profiling ◽

Positive Breast Cancer

Download Full-text

Abstract 1937: Development of microRNA-based prediction model of Trastuzumab treatment response for HER2-positive breast cancer using FFPE specimens.

10.1158/1538-7445.am2013-1937 ◽

2013 ◽

Author(s):

Fumiaki Sato ◽

Zhipeng Wang ◽

Takayuki Ueno ◽

Akira Myomoto ◽

Satoko Takizawa ◽

...

Keyword(s):

Breast Cancer ◽

Prediction Model ◽

Treatment Response ◽

Her2 Positive ◽

Trastuzumab Treatment ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

Abstract P5-16-21: The association of higher tumor HER2 load with treatment response to neoadjuvant therapy in HER2 positive breast cancer patients

10.1158/1538-7445.sabcs16-p5-16-21 ◽

2017 ◽

Author(s):

TJ Lillemoe ◽

B Susnik ◽

E Grimm ◽

S-HL Kang ◽

KK Swenson ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Therapy ◽

Treatment Response ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

Review of treatment strategies for HER2 positive breast cancer and their implementation in a major Swiss hospital

10.1055/s-0040-1710671 ◽

2020 ◽

Author(s):

F Geissler ◽

M Vetter ◽

A Schoetzau ◽

C Montavon ◽

C Kurzeder ◽

...

Keyword(s):

Breast Cancer ◽

Treatment Strategies ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with neoadjuvant chemotherapy: Sequential analysis

10.26226/morressier.596dfd55d462b80292386fa4 ◽

2017 ◽

Author(s):

You-Jeong Seo

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Cancer Patients ◽

Sequential Analysis ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Pik3ca Mutations ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

Hypoxia up-regulates ID proteins in Luminal and HER2-positive breast cancer cell lines

10.26226/morressier.5b4709836f4cb30010951ad8 ◽

2018 ◽

Author(s):

Gloria Peiro Cabrera

Keyword(s):

Breast Cancer ◽

Cancer Cell ◽

Breast Cancer Cell ◽

Breast Cancer Cell Lines ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Id Proteins ◽

Positive Breast Cancer Cell ◽

Positive Breast Cancer

Download Full-text

FDA approves fam-trastuzumab deruxtecan-nxki for unresectable or metastatic HER2-positive breast cancer

Case Medical Research ◽

10.31525/cmr-24bd324 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

FDA approves new treatment option for patients with HER2-positive breast cancer who have progressed on available therapies

Case Medical Research ◽

10.31525/cmr-24bb59f ◽

2019 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Treatment Option ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

New Treatment ◽

Positive Breast Cancer

Download Full-text